CC BY-NC-ND 4.0 · Indian Journal of Neurosurgery 2020; 9(02): 085-088
DOI: 10.1055/s-0040-1710107
Original Article

Management of Idiopathic Intracranial Hypertension: Experience of a North African Center

Ibrahim Assoumane
1   Department of Neurosurgery, CHU Bab El Oued, Algiers, Algeria
2   Department of Neurosurgery, Maradi Reference Hospital, Niger Republic
,
Mahdia Touati
1   Department of Neurosurgery, CHU Bab El Oued, Algiers, Algeria
,
Harissou Adamou
3   Department of General Surgery, Faculty of Health Sciences, University of Zinder, National Hospital, Zinder, Niger Republic
,
Nadia Lagha
1   Department of Neurosurgery, CHU Bab El Oued, Algiers, Algeria
,
Ibrahim Baaré
4   Department of Ophthalmology, Maradi Reference Hospital, Niger Republic
,
Samuila Sanoussi
5   Department of Neurosurgery, Niamey National Hospital, Niger Republic
,
Abderahmanne Sidi Said
1   Department of Neurosurgery, CHU Bab El Oued, Algiers, Algeria
,
Abdelhalim Morsli
1   Department of Neurosurgery, CHU Bab El Oued, Algiers, Algeria
› Author Affiliations

Abstract

Background The idiopathic intracranial hypertension (IIH) is characterized by elevation of intracranial pressure (ICP) in the absence of intracerebral space occupation or venous sinus thrombosis. It usually occurs in obese young women but is very rare in childhood.

Materials and Methods We conducted a retrospective study in the neurosurgical department of Bab El Oued teaching hospital of Algiers over a period of 8 years from January 2008 to December 2015. We analyzed clinical data of 10 patients with IIH diagnosis, and the surgical technique consisted of an insertion of a lumbo-peritoneal shunt.

Results In our study, 80% were women with sex ratio M/F of 0.25; the mean age was 32 years and 60% of our patients were obese. For most of our patients, the postoperative outcome was marked by the disappearance of the headache immediately, disappearance of strabismus and diplopia in the following week, followed by improvement of visual function.

Conclusion The IIH is predominantly a disease of women in the childbearing age; surgical treatment is a good option for patients who resisted medication or did not tolerate it as well as for ICH fulminous in emergency cases.



Publication History

Article published online:
15 June 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Bjornson A, Tapply I, Nabbanja E. et al. Ventriculo-peritoneal shunting is a safe and effective treatment for idiopathic intracranial hypertension. Br J Neurosurg 2019; 33 (01) 62-70
  • 2 Karsy M, Abou-Al-Shaar H, Bowers CA, Schmidt RH. Treatment of idiopathic intracranial hypertension via stereotactic placement of biventriculoperitoneal shunts. J Neurosurg 2018; 130 (01) 136-144
  • 3 Baykan B, Ekizoğlu E, Altıokka Uzun G. An update on the pathophysiology of idiopathic intracranial hypertension alias pseudotumor cerebri. Agri 2015; 27 (02) 63-72
  • 4 Akçakaya NH, Akçakaya MO, Sencer A, Yapici Z. Idiopathic intracranial hypertension: diagnosis and therapeutic approach. Turk J Neurol 2017; 23 (02) 43-50
  • 5 De Simone R, Ranieri A, Bonavita V. Advancement in idiopathic intracranial hypertension pathogenesis: focus on sinus venous stenosis. Neurol Sci 2010; 31 (01) (Suppl. 01) S33-S39
  • 6 Spitze A, Malik A, Lee AG. Surgical and endovascular interventions in idiopathic intracranial hypertension. Curr Opin Neurol 2014; 27 (01) 69-74
  • 7 Smith SV, Friedman DI. The idiopathic intracranial hypertension treatment trial: a review of the outcomes. Headache 2017; 57 (08) 1303-1310
  • 8 Ali AK, Shousha MM, Metwally MR. Management of pseudo tumor cerebri by frequent tapping vs lumboperitoneal shunt. Egypt J Hosp Med 2018; 72 (05) 4556-4560
  • 9 Grant DN. Benign intracranial hypertension. A review of 79 cases in infancy and childhood. Arch Dis Child 1971; 46 (249) 651-655
  • 10 De Simone R, Ranieri A, Montella S, Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 2014; 82 (11) 1011-1012
  • 11 Barmherzig R, Szperka CL. Pseudotumor cerebri syndrome in children. Curr Pain Headache Rep 2019; 23 (08) 58
  • 12 Skau M, Brennum J, Gjerris F, Jensen R. What is new about idiopathic intracranial hypertension? An updated review of mechanism and treatment. Cephalalgia 2006; 26 (04) 384-399
  • 13 Rehder D. Idiopathic intracranial hypertension: review of clinical syndrome, imaging findings, and treatment. Curr Probl Diagn Radiol 2019; S0363-0188(18)30257-3
  • 14 Riggeal BD, Bruce BB, Saindane AM. et al. Clinical course of idiopathic intracranial hypertension with transverse sinus stenosis. Neurology 2013; 80 (03) 289-295
  • 15 Kalyvas AV, Hughes M, Koutsarnakis C. et al. Efficacy, complications and cost of surgical interventions for idiopathic intracranial hypertension: a systematic review of the literature. Acta Neurochir (Wien) 2017; 159 (01) 33-49
  • 16 Burgett RA, Purvin VA, Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. Neurology 1997; 49 (03) 734-739
  • 17 Eggenberger ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology 1996; 46 (06) 1524-1530
  • 18 Gupta B, Panigrahi M. Acquired Chiari I malformation following a lumbo-peritoneal shunt–William’s hypothesis revisited. J Med Sci Res 2013; 1 (01) 13-15
  • 19 Moataz AE, Elmaghrabi MM. Neurological and ophthalmological recovery after lumbo-peritoneal shunting as a treatment of idiopathic intracranial hypertension. Int J Adv Res (Indore) 2017; 5 (09) 914-920
  • 20 Sinclair AJ, Kuruvath S, Sen D, Nightingale PG, Burdon MA, Flint G. Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review. Cephalalgia 2011; 31 (16) 1627-1633
  • 21 Wakerley BR, Tan MH, Ting EY. Idiopathic intracranial hypertension. Cephalalgia 2015; 35 (03) 248-261
  • 21 Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002; 59 (10) 1492-1495